Helping people understand overseas medical information through precise language
FTH Co., Ltd. supports medical information guidance, medical document translation and on-site interpreting in Japan's stem cell and regenerative medicine field.
AI-generated image · not real people or institutions
Medical language support focused on stem cells
Most overseas information on regenerative medicine is in Japanese or English and uses many specialist terms that distinguish cell types, regulations and study phases. FTH focuses on rendering this information accurately in Korean.
FTH summarises stem cell information from published papers and public-agency sources, translates medical documents prepared by our clients, and supports interpreting at explanations in Japan.
Our role
- Information on stem cell research in Japan
- Translation and Korean summaries of published papers and materials
- On-site interpreting and communication support in Japan
Information principles
- Accuracy
- Objectivity
- Sources cited
- Up-to-date information
Fields we cover
- Autism, Developmental Disorders & Cerebral Palsy
- Brain Disorders (Stroke, Parkinson's, Dementia, ALS, MS)
- Spinal Cord Injury & Knee Joints
- Heart, Liver & Diabetes
- Women's Health & Ageing
- Regulation & Other (Crohn's, Pain, etc.)
For users
- Medical judgements are made by the medical team
- No wording that guarantees treatment results
- No false or exaggerated information
Company information
| Company | FTH Co., Ltd. |
|---|---|
| Address | 313 Central-ro, Yeonsu-gu, Incheon 22006, Republic of Korea (Songdo-dong, Songdo C-Walk In Terrace Halla) |
| Phone | 02-517-5117 |
| 1004@109.co.kr | |
| Website | https://104.seoul.kr/ |
FTH is not a medical institution but a company providing stem cell research information and translation and interpreting services. We share general research information based on published academic sources; we do not diagnose, treat or make medical judgements, and our purpose is to provide information and on-site interpreting.